ESCA

For various off-label neuro-immunological conditions ONLY if proposed treatment pathway is  approved at MDT

• Amber - specialist initation following diagnosis of AF- use in line with NICE. Initiation/ recommendation by a clinician who routinely initiates anticoagulants
• Amber - specialist initation for the treatment and secondary prevention of DVT and/or PE - use in line with NICE. Initiation/ recommendation by a clinician who routinely initiates anticoagulants. Where this is not the patient's GP, transfer to GP should be with the support of RICaD
• Amber - specialist initiation for preventing adverse outcomes after acute management of ACS use in line with NICE TA335. Initiation/recommendation by a clinician who routinely initiates anticoagulants. Where this is not the patient's GP, transfer to GP should be with the support of RICaD

Use following Hip and Knee surgery- full course of treatment supplied on discharge.

Dementia drugs ESCA

Dementia drugs ESCA

Reserved for patients who are vomiting due to migraine